Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

The United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. While randomized clinical trials were in var...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Jonathon W. Senefeld, Patrick W. Johnson, Katie L. Kunze, Evan M. Bloch, Noud van Helmond, Michael A. Golafshar, Stephen A. Klassen, Allan M. Klompas, Matthew A. Sexton, Juan C. Diaz Soto, Brenda J. Grossman, Aaron A.R. Tobian, Ruchika Goel, Chad C. Wiggins, Katelyn A. Bruno, Camille M. van Buskirk, James R. Stubbs, Jeffrey L. Winters, Arturo Casadevall, Nigel Paneth, Beth H. Shaz, M. Petersen, Bruce S. Sachais, Matthew Buras, Mikolaj A. Wieczorek, Benjamin Russoniello, Larry J. Dumont, Sarah E. Baker, Ralph Vassallo, John R.A. Shepherd, Pampee P. Young, Nicole Verdun, Peter Marks, Nancy Haley, Robert F. Rea, Louis M. Katz, Vitaly Herasevich, Dan A. Waxman, Emily R. Whelan, Aviv Bergman, Andrew J. Clayburn, M. Kate Grabowski, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, Matthew N.P. Vogt, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Zachary A. Buchholtz, Michaela C. Pletsch, Katherine Wright, Joel T. Greenshields, Michael J. Joyner, R. Scott Wright, Rickey E. Carter, DeLisa Fairweather
Materialtyp: Artigo
Språk:engelska
Publicerad: 2021
Länkar:https://doi.org/10.1371/journal.pmed.1003872
https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003872&type=printable
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!